5 Things in ePharmacy You Need to Know This Friday 10/11/23
eCommerce [🇺🇸]
Amazon Beefs Up Prime Loyalty Program with One Medical Discount
Amazon is beefing up its mainstay Prime subscription program with a new benefit that gives members access to discounted One Medical memberships. The company announced Wednesday that Prime members will be able to sign up for One Medical at a rate of $9 per month, or $99 a year, versus the standard cost of $199 annually, or $16.59 a month. Prime members can add up to five additional memberships on the same plan at a rate of $6 per person, Amazon said.
Read more: CNBC
What’s New [🇮🇳]
TrueMeds Revolutionizes Indian Online Pharmacies, Emerging as Game Changer
In a transformative stride for India's online pharmacy sector, TrueMeds emerges as a game-changer, as reported by Hindustan Times. The brand story explores TrueMeds' innovative approach, emphasizing accessibility, affordability, and authenticity in pharmaceutical services. With a focus on quality and customer trust, TrueMeds is reshaping the landscape, providing a reliable alternative for healthcare needs. Dive into the unfolding narrative of TrueMeds, marking a significant shift in the dynamics of the Indian online pharmacy realm.
Read more: Hindustan Times
What’s New [🇧🇪]
ePharmacy Sector Advocates Accessible and Affordable Medicines in Europe
The European Association of ePharmacies (EAEP) hosted an event in Brussels on Thursday, 26 October 2023, on “The EU Pharmaceutical Legislation – setting the right framework conditions for pharmacies”. On the occasion, EU representatives, industry stakeholders, patient organisations and e-pharmacies held an exchange on the ambitious revision of the existing rules governing the pharma sector, put forward by the European Commission. In a call for action, the e-pharmacy sector urges robust measures to ensure the availability, accessibility, and affordability of medicines across Europe.
Read more: The European Association of ePharmacies
What’s New [🇹🇼]
Taiwan’s Food and Drug Administration Warns Consumers about Online Drug Purchases
Taiwan's FDA issues a cautionary alert regarding the surge in illegal and counterfeit online medicine sales, citing a growing threat to public health. The agency warns of unlicensed "pharmacies" operating without prescriptions, selling substandard or fake pharmaceuticals. The proliferation of overseas-based websites disguising as legitimate online pharmacies compounds the risk, offering medicines of dubious origin that may lack active ingredients or even pose harm. The FDA emphasizes the violation of the Pharmaceutical Affairs Act, highlighting the pressing need for public awareness and regulatory measures.
Read more: Focus Taiwan
Editor’s Choice 🌍
BeSafeRx: Food and Drug Administration's Fight Against Online Pharmacy Perils in the US
In a proactive stance, the Food and Drug Administration intensifies its battle against the rising threat of illegal online pharmacies through the BeSafeRx campaign. The campaign has a pivotal role in educating consumers about the risks associated with purchasing medications from unverified online sources. As the digital landscape continues to reshape pharmaceutical transactions, this report sheds light on the FDA's commitment to safeguarding public health, emphasizing the need for heightened awareness and caution.
Read more: Specialty Pharmacy Continuum
Manufacturers & Retailers Hiring Now:
Discover actively recruiting positions in the ePharmacy Industry below:
CRM & Commercial Systems Lead, Stada [🇩🇪]
More info: LinkedIn
Head of Product Analytics & Pricing, DocMorris [🇩🇪]
More info: LinkedIn
Digital Logistics & Customer Care Business Partner, Sanofi [🇪🇸]
More info: LinkedIn
Senior Digital Manager, Perrigo [🇧🇪]
More info: LinkedIn
Digital Transformation Manager, Boehringer Ingelheim [🇩🇪]
More info: LinkedIn
Thank you for being with us for this week! In case you found ePharmacy News interesting please do not hesitate to share it.
🕵️ Send a confidential scoop to ePharmacy News: news@epharmacynews.com